<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang X</submitter><funding>NCI NIH HHS</funding><pagination>737-746</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6592777</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(7)</volume><pubmed_abstract>Ligand-dependent protein degradation has emerged as a compelling strategy to pharmacologically control the protein content of cells. So far, however, only a limited number of E3 ligases have been found to support this process. Here, we use a chemical proteomic strategy that leverages broadly reactive, cysteine-directed electrophilic fragments coupled to selective ligands for intracellular proteins (for example, SLF for FKBP12, JQ1 for BRD4) to screen for heterobifunctional degrader compounds (or proteolysis targeting chimeras, PROTACs) that operate by covalent adduction of E3 ligases. This approach identified DCAF16-a poorly characterized substrate recognition component of CUL4-DDB1 E3 ubiquitin ligases-as a target of electrophilic PROTACs that promote the nuclear-restricted degradation of</pubmed_abstract><journal>Nature chemical biology</journal><pubmed_title>Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16.</pubmed_title><pmcid>PMC6592777</pmcid><funding_grant_id>K00 CA212467</funding_grant_id><funding_grant_id>R50 CA211526</funding_grant_id><funding_grant_id>R37 CA087660</funding_grant_id><funding_grant_id>R35 CA231991</funding_grant_id><pubmed_authors>Crowley VM</pubmed_authors><pubmed_authors>Dix MM</pubmed_authors><pubmed_authors>Cravatt BF</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Wucherpfennig TG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16.</name><description>Ligand-dependent protein degradation has emerged as a compelling strategy to pharmacologically control the protein content of cells. So far, however, only a limited number of E3 ligases have been found to support this process. Here, we use a chemical proteomic strategy that leverages broadly reactive, cysteine-directed electrophilic fragments coupled to selective ligands for intracellular proteins (for example, SLF for FKBP12, JQ1 for BRD4) to screen for heterobifunctional degrader compounds (or proteolysis targeting chimeras, PROTACs) that operate by covalent adduction of E3 ligases. This approach identified DCAF16-a poorly characterized substrate recognition component of CUL4-DDB1 E3 ubiquitin ligases-as a target of electrophilic PROTACs that promote the nuclear-restricted degradation of</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jul</publication><modification>2025-04-19T23:41:47.32Z</modification><creation>2020-05-21T23:04:45Z</creation></dates><accession>S-EPMC6592777</accession><cross_references><pubmed>31209349</pubmed><doi>10.1038/s41589-019-0279-5</doi></cross_references></HashMap>